Sun Pharma
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Sun House cts no. 201 b/1 Western Expres...Phone Number
+91 2243244324Website
www.sunpharma.comRevenue
$6.2 BillionStock Symbol
SUNPHARMAIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
14
1
2
2
2
2
About Sun Pharma
Sun Pharma is a specialty generic pharmaceutical company that manufactures and distributes pharmaceutical formulations and active pharmaceutical ingredients. It is heaquartered in Mumbia, India.Explore more
Sun Pharma Org Chart
DS
Regional Finance Controller
KG
Regional Financial Controller
AG
Plant Finance Controller
KB
Manager - Plant Financial Controller
DP
Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sun Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sun Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sun Pharma has new funding data
Check out if Sun Pharma is spiking on competitors!
Earning: See what the market has to say on Sun Pharma recently announced quarterly report
Product Launch: Get notified when Sun Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sun Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sun Pharma
Click to see if Sun Pharma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Sun Pharma
Compare insights from companies similar to Sun Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$56.7B
10K+
Public
-
1996
DC
Daniela CastanedaImmunology Director, Commercial Operations & Chief of Staff
Company Profile Activity
Activity Insights
Sun Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sun Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sun Pharma.
Sun Pharma Tech Stack
A closer look at the technologies used by Sun Pharma
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Sun Pharma News & Media
Sun Pharma to acquire Innovcare Lifesciences for $28.7m
Sun Pharma expects to close the acquisition on or before 31 July 2026.AMERICAN SKIN ASSOCIATION ANNUAL GALA RECOGNIZES SUN PHARMA WITH CORPORATE LEADERSHIP AWARD
Specialty and Generic Medicines Leader Honored for Dedication to the Dermatology Field NEW YORK, June 3, 2026 /PRNewswire/ -- On Tuesday evening at The Plaza Hotel, American Skin Association (ASA) held its Annual Gala, which celebrated another successful year of funding research and youth...At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT™ (cosibelimab-ipdl)
Nearly 27% of patients experienced a complete response; median duration of response not reached; only 1 patient experienced a Grade >3 immune-related adverse event Second Largest Prospective Study of Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patients MUMBAI, India and...Sun Pharma signs Definitive Agreement to Acquire Organon | Business Wire - Via TT
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sun Pharma
Sign Up For FreeTo access detailed company insights
Sun Pharma is a specialty generic pharmaceutical company that manufactures and distributes pharmaceutical formulations and active pharmaceutical ingredients. It is heaquartered in Mumbia, India.... Read More
